Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer
- L. Kanczuga-Koda, S. Sulkowski, +4 authors M. Sułkowska
- Medicine
- Journal of Clinical Pathology
- 1 April 2006
Background: Gap junctions are intercellular channels composed of connexins, which mediate the direct passage of small molecules between neighbouring cells. They are involved in regulation of cell… Expand
Increased Expression of Leptin and the Leptin Receptor as a Marker of Breast Cancer Progression: Possible Role of Obesity-Related Stimuli
- C. Garofalo, M. Koda, +6 authors E. Surmacz
- Medicine
- Clinical Cancer Research
- 1 March 2006
Purpose: Recent in vitro studies suggested that the autocrine leptin loop might contribute to breast cancer development by enhancing cell growth and survival. To evaluate whether the leptin system… Expand
Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.
- E. Skrzydlewska, M. Sułkowska, M. Koda, S. Sulkowski
- Biology, Medicine
- World journal of gastroenterology
- 7 March 2005
Cancer development is essentially a tissue remodeling process in which normal tissue is substituted with cancer tissue. A crucial role in this process is attributed to proteolytic degradation of the… Expand
Lipid peroxidation and antioxidant status in colorectal cancer.
- E. Skrzydlewska, S. Sulkowski, M. Koda, B. Zalewski, L. Kanczuga-Koda, M. Sułkowska
- Chemistry, Medicine
- World journal of gastroenterology
- 21 January 2005
AIM
Reactive oxygen species (ROS) can induce carcinogenesis via DNA injury. Both enzymatic and non-enzymatic parameters participate in cell protection against harmful influence of oxidative stress.… Expand
Overexpression of the obesity hormone leptin in human colorectal cancer
- M. Koda, M. Sułkowska, L. Kanczuga-Koda, E. Surmacz, S. Sulkowski
- Medicine
- Journal of Clinical Pathology
- 17 October 2006
Background: Leptin is an adipocyte-derived neurohormone, high levels of which are found in obese individuals. Leptin controls energy expenditure, acting in the brain, and regulates different… Expand
Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer.
- L. Kanczuga-Koda, S. Sulkowski, +5 authors M. Baltaziak
- Biology, Medicine
- Oncology reports
- 1 August 2005
Apoptosis is a process associated with development and progression of breast cancer. The association between connexins and programmed cell death has only been demonstrated in a few studies. The aim… Expand
Expression of Leptin, Leptin Receptor, and Hypoxia‐Inducible Factor 1α in Human Endometrial Cancer
- M. Koda, M. Sułkowska, +4 authors S. Sulkowski
- Biology, Medicine
- Annals of the New York Academy of Sciences
- 1 January 2007
Abstract: Recent studies suggested that Ob (Ob) and its receptor (ObR) could be involved in the pathogenesis of various human malignancies, among others in endometrial cancer. Moreover, hypoxia,… Expand
Expression of connexins 26, 32 and 43 in the human colon--an immunohistochemical study.
- L. Kanczuga-Koda, S. Sulkowski, M. Koda, M. Sobaniec-Lotowska, M. Sułkowska
- Biology, Medicine
- Folia histochemica et cytobiologica
- 2004
Gap junctional intercellular communication (GJIC) is a mechanism for direct cell-to-cell signalling and is mediated by gap junctions (GJs), which consist of proteins called connexins (Cxs). GJIC… Expand
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases
- M. Koda, M. Sułkowska, L. Kanczuga-Koda, S. Sulkowski
- Biology, Medicine
- Journal of Clinical Pathology
- 1 June 2005
Background: Insulin receptor substrate 1 (IRS-1) transmits signals from the insulin-like growth factor I receptor (IGF-IR) and insulin receptor (IR) and has been associated with the pathogenesis of… Expand
Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues.
- K. Sugihara, S. Nakano, M. Koda, K. Tanaka, N. Fukuishi, M. Gemba
- Chemistry, Medicine
- Japanese journal of pharmacology
- 1987
Cisplatin (cis-diamminedichloroplatinum II), an anticancer chemotherapeutic agent with the dose-limiting side effect of nephrotoxicity, caused a statistically significant increase in lipid… Expand